Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer.

NCT01924533 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

525

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Olaparib
DRUG: Paclitaxel
DRUG: Placebo

Sponsor

AstraZeneca